Aligned Genetics Balance Sheet Health
Financial Health criteria checks 5/6
Aligned Genetics has a total shareholder equity of ₩31.3B and total debt of ₩3.9B, which brings its debt-to-equity ratio to 12.5%. Its total assets and total liabilities are ₩40.9B and ₩9.6B respectively. Aligned Genetics's EBIT is ₩3.3B making its interest coverage ratio 62.6. It has cash and short-term investments of ₩14.9B.
Key information
12.5%
Debt to equity ratio
₩3.90b
Debt
Interest coverage ratio | 62.6x |
Cash | ₩14.93b |
Equity | ₩31.31b |
Total liabilities | ₩9.62b |
Total assets | ₩40.93b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A238120's short term assets (₩21.6B) exceed its short term liabilities (₩5.2B).
Long Term Liabilities: A238120's short term assets (₩21.6B) exceed its long term liabilities (₩4.4B).
Debt to Equity History and Analysis
Debt Level: A238120 has more cash than its total debt.
Reducing Debt: A238120's debt to equity ratio has increased from 0% to 12.5% over the past 5 years.
Debt Coverage: A238120's debt is well covered by operating cash flow (73%).
Interest Coverage: A238120's interest payments on its debt are well covered by EBIT (62.6x coverage).